Julie Johnson, PharmD, FCCP, BCPS
Professor and Chair Dept. Pharmacy Practice
Professor of Pharmaceutics
V. Ravi Chandran Professor in Pharmaceutical Sciences
Professor of Medicine (Cardiology)
Director, UF Center for Pharmacogenomics
Biographical Sketch
Julie A. Johnson, Pharm.D., FCCP, BCPS is the V. Ravi Chandran Professor of Pharmaceutical Sciences, Professor and Chair of the the Department of Pharmacy Practice, Professor of Pharmaceutics and Professor of Medicine (Cardiovascular Medicine) at the University of Florida Colleges of Pharmacy and Medicine, and Director, University of Florida Center for Pharmacogenomics. She joined the faculty at the University of Florida in May 1998. Prior to her appointment on the UF faculty, she spent 9 years on the University of Tennessee College of Pharmacy faculty. She received her B.S. in Pharmacy from the Ohio State University and her Pharm.D. from the University of Texas at Austin and the University of Texas Health Science Center at San Antonio. Following her Pharm.D., she completed a post-doctoral fellowship in cardiovascular pharmacology/ pharmacokinetics at the Ohio State University.
Dr. Johnson’s research focus is cardiovascular drug pharmacogenomics, and disease-gene associations that may be relevant to pharmacogenomics, and the influence of race/ethnicity on drug response and pharmacogenomics. The majority of her research centers around efforts in hypertension, heart failure, with a primary focus on proteins that are drug targets and the impact of their genetic polymorphisms on drug response and disease. Her research has been continuously funded by the National Institutes of Health or the American Heart Association since 1990. She recently became a member of the NIH Pharmacogenetics Research Network, with a project focused on pharmacogenomics of antihypertensive drugs.
Dr. Johnson served on the Nonprescription Drugs Advisory Committee of the Food and Drug Administration (2000-2004), and is also serving a five year term on the Pediatric Heart Disease Clinical Research Network Protocol Review Committee for the National Heart Lung and Blood Institute at NIH. She also served as a Regent of the American College of Clinical Pharmacy (2000-2003). She is on the editorial boards of the journals Pharmacogenetics and Genomics, Clinical Pharmacology and Therapeutics and Personalized Medicine, is a scientific editor for Pharmacotherapy and serves as manuscript reviewer for numerous other scientific journals.
Dr. Johnson’s awards include the University of Tennessee Excellence in Teaching Award from the Student Government Association (1996), induction as Fellow of the American College of Clinical Pharmacy (1996), the Ohio State University Alumni Association William Oxley Thompson Award for early career achievement (1997), the Outstanding Faculty Award from the University of Florida Working Professional Pharm.D. Program (2001), the Philip C. and Ethel E. Ashby Lecturer at the University of Oklahoma (2003), the Albert Ebert 31st Annual Lecturer at University of Illinois (2003), the Leon I Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics (2004), receipt of a University of Florida Research Foundation Professorship (2004-2006), naming as the V. Ravi Chandran Professor in Pharmaceutical Sciences (2004), and the Distinguished Alumnus Award from the Ohio State University College of Pharmacy (2005).
